全文获取类型
收费全文 | 9402篇 |
免费 | 879篇 |
国内免费 | 547篇 |
专业分类
耳鼻咽喉 | 83篇 |
儿科学 | 166篇 |
妇产科学 | 120篇 |
基础医学 | 1163篇 |
口腔科学 | 124篇 |
临床医学 | 1231篇 |
内科学 | 1720篇 |
皮肤病学 | 101篇 |
神经病学 | 495篇 |
特种医学 | 574篇 |
外国民族医学 | 1篇 |
外科学 | 802篇 |
综合类 | 1005篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 579篇 |
眼科学 | 429篇 |
药学 | 1096篇 |
7篇 | |
中国医学 | 382篇 |
肿瘤学 | 745篇 |
出版年
2024年 | 26篇 |
2023年 | 136篇 |
2022年 | 314篇 |
2021年 | 385篇 |
2020年 | 305篇 |
2019年 | 268篇 |
2018年 | 264篇 |
2017年 | 245篇 |
2016年 | 229篇 |
2015年 | 398篇 |
2014年 | 417篇 |
2013年 | 451篇 |
2012年 | 592篇 |
2011年 | 625篇 |
2010年 | 425篇 |
2009年 | 287篇 |
2008年 | 442篇 |
2007年 | 465篇 |
2006年 | 411篇 |
2005年 | 407篇 |
2004年 | 308篇 |
2003年 | 270篇 |
2002年 | 268篇 |
2001年 | 254篇 |
2000年 | 226篇 |
1999年 | 248篇 |
1998年 | 172篇 |
1997年 | 180篇 |
1996年 | 170篇 |
1995年 | 167篇 |
1994年 | 102篇 |
1993年 | 111篇 |
1992年 | 124篇 |
1991年 | 119篇 |
1990年 | 100篇 |
1989年 | 152篇 |
1988年 | 101篇 |
1987年 | 98篇 |
1986年 | 77篇 |
1985年 | 66篇 |
1984年 | 58篇 |
1983年 | 40篇 |
1982年 | 44篇 |
1981年 | 43篇 |
1980年 | 39篇 |
1979年 | 36篇 |
1978年 | 26篇 |
1977年 | 31篇 |
1976年 | 33篇 |
1975年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
3.
我国属胃癌高发国家,且以进展期胃癌为主。以手术和化疗为主的多学科治疗无法有效改善晚期胃癌患者的预后。近年来,免疫检查点抑制剂类药物的疗效在诸多癌症中得到了证实,因此,该类药物在胃癌中的治疗效果也受到了广泛的关注。本文对近年来的相关研究成果进行综述,全面介绍了免疫检查点抑制剂类药物在胃癌治疗中的临床应用情况、联合用药情况以及不良反应。对于其他治疗均失败的晚期胃癌患者,PD-1抑制剂是一个可行的治疗选项,其代表药物派姆单抗是目前唯一被美国食品药品监督管理局批准应用于胃癌治疗的免疫抑制剂类药物,而我国国家食品药品监督管理总局尚未批准任何此类药物应用于胃癌的临床治疗。如何进一步提高治疗的客观缓解率,将会是后续临床和基础研究的一大焦点。 相似文献
4.
5.
6.
7.
8.
同步放化疗是不可手术局部晚期食管癌的标准治疗模式,国际推荐根治性放疗剂量为50.0~50.4Gy,但中国食管癌与西方国家在病理类型、生物学行为等方面大有不同,行根治性放疗剂量仍倾向于60Gy。增加放疗剂量能否带来生存获益成为临床亟待解决的问题。有研究认为高剂量放疗可提高局控率、改善生存,但也有研究认为提高剂量未能带来生存获益,且可增加不良反应事件发生率。因此,本文就食管癌根治性放疗剂量对预后的影响进行探讨,并通过放化疗后疗效评估对放疗剂量做出适当调整,以期达个体化放疗。 相似文献
9.
To determine if impaired energy metabolism might contribute to some aspects of Alzheimer disease (AD), including the vulnerability of the CA1 region of the hippocampal formation and the altered cytoskeleton evident in neurofibrillary tangles, we examined the effects of metabolic poisons on neuronal damage and cytoskeletal disruption in the hippocampal formation. Intrahippocampal injection of 3-nitropropionic acid (3-NP) and malonic acid resulted in neuronal death, particularly in CA1. Cytoskeletal disruption included loss of dendritic MAP2, but sparing of axonal τ. MK-801 (a noncompetitive NMDA receptor antagonist) did not atenuate the lesions produced by intrahippocampal injection of malonate. MK-801, however, was effective against intrastriatal malonate. Acute systemic 3-NP resulted in neuronal damage and cytoskeletal disruption in the CA1 region of the hippocampal formation, including an extensive loss of MAP2 immuno-reactivity, but sparing of τ. The neuronal loss in CA1 was delayed as compared to striatum. Chronic intraventricular infusion of 3-NP produced a different pattern of neuronal damage. Loss of τ-1 immuno-reactivity was observed in CA3 and CA1 s. oriens, whereas MAP2 immunostaining was preserved. These results demonstrate that chronic and acute administration of metabolic inhibitors produce distinct patterns of neuronal damage and cytoskeletal disruption. The results further suggest a differential involvement of the NMDA receptor in malonate-induced neuronal damage in striatum as compared to the hippocampus. The pattern of neuronal damage and cytoskeletal disruption observed following acute metabolic impairment resembled some aspects of neurofibrillary pathology in AD, but did not result in τ hyperphosphorylation. 相似文献
10.
本文对17例肾病综合征(NS)患儿和15例健康对照组儿童血红细胞磷脂过氧化氢谷胱甘肽过氧化物酶(PHGPx)活力,脂溶性荧光色素(LSFP)含量进行了研究。结果表明,NS急性期PHGPx活力明显降低.LSFP含量增加;恢复期PHGPx活力较急性期明显提高,但仍低于正常对照组,LSFP虽较急性期下降,但仍高于正常对照组。说明NS存在PHGPx和LSFP的改变,但可逐渐恢复。 相似文献